Top Stock Movers: NTRB, OWUV, MESO
2:57 pm Friday, December 31st, 2021
Nutriband (NASDAQ:NTRB) is soaring after the Korean Intellectual Property Office (KIPO) fully issued its patent named Abuse and Misuse Deterrent Transdermal System, related to the company’s lead technology AVERSA. The company said the patent underpins 4p Therapeutics’ abuse deterrent transdermal system, AVERSA, which uses taste aversion to address the primary routes of abuse for opioid based transdermal patches. The KIPO had issued a prior notice of allowance in December 2020.
One World Universe (OTCPK:OWUV) received a third warehouse building valued at $2.5M; all three buildings will add $6M in property value to the company. All of the buildings are “free and clear”, have no liens, and all the buildings will bring immediate value, additional cash flow into the holding company and will be used for their newly created Medi-Natural Seeds and CBD company.
Mesoblast (NASDAQ:MESO) will provide data on the in vitro immunomodulatory activity of remestemcel-L for steroid-refractory acute graft-versus-host disease (SR-aGVHD) to the FDA as part of its BLA resubmission. The company now believes it has enough data to establish the relevance of the proposed in vitro immunomodulatory activity of remestemcel-L to the in vivo clinical effect in the Phase 3 trial in children with SR-aGVHD.
